Interleukin-18 polymorphism as a diagnostic tumor marker for hepatocellular carcinoma in patients with hepatitis C-related cirrhosis

Interleukin-18 polymorphism as a diagnostic tumor marker for hepatocellular carcinoma in patients with hepatitis C-related cirrhosis

Abstract Background Egypt has the highest hepatitis C virus prevalence worldwide where about 24% of the people are estimated to carry HCV and more than 50% of blood donors have anti-HCV in some towns. The burden of hepatocellular carcinoma has been increasing in Egypt with a doubling in the incidenc...

Full description

Bibliographic Details
Main Authors: Ayman Abdelghaffar Eldesoky, Nancy Abdel Fattah Ahmed, Hosam Eldeen Zaghloul, Amr Ahmed Abdel Aziz
Format: Article
Language:English
Published: SpringerOpen 2020-11-01
Series:Egyptian Liver Journal
Subjects:
HCV
HCC
SNPs
Online Access:http://link.springer.com/article/10.1186/s43066-020-00062-8

Similar Items

Similar Items